The Role of Angiotensin-Converting Enzyme Inhibitors and β-Blockers in Primary Prevention of Cardiac Dysfunction in Breast Cancer Patients

J Am Heart Assoc. 2020 Jan 21;9(2):e015327. doi: 10.1161/JAHA.119.015327. Epub 2020 Jan 21.

Authors

Sherry-Ann Brown¹, Tochi M Okwuosa², Ana Barac³, Annabelle Santos Volgman²

Affiliations

¹ Department of Cardiovascular Disease Mayo Clinic Rochester MN.
² Division of Cardiology Department of Medicine Rush University Medical Center Chicago IL.
³ Department of Cardiology MedStar Heart and Vascular Institute Georgetown University Washington DC.

No abstract available

Keywords: cardiomyopathy; cardioprotection; cardiotoxicity; cardiovascular complications; cardiovascular disease prevention.

Publication types

Review

MeSH terms

Adrenergic beta-Antagonists / therapeutic use*
Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
Antineoplastic Agents / adverse effects*
Breast Neoplasms / drug therapy*
Cardiotoxicity
Female
Heart Disease Risk Factors
Heart Diseases / chemically induced
Heart Diseases / physiopathology
Heart Diseases / prevention & control*
Humans
Primary Prevention*
Protective Factors
Risk Assessment
Treatment Outcome

Substances

Adrenergic beta-Antagonists
Angiotensin-Converting Enzyme Inhibitors
Antineoplastic Agents